H-1B sponsorship profile: Genesis Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Genesis Therapeutics Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Genesis Therapeutics Inc’s H-1B petitions range from $145,000 at the low end to $250,000 at the high end, with a petition-weighted average of $205,063. That range reflects the mix of occupations the company sponsors, led by Sr ML Research Scientist (1 petitions at $250,000 avg), followed by Software Engineer and Senior Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Genesis Therapeutics Inc is headquartered in Burlingame, CA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Genesis Therapeutics Inc ranks. By H-1B petition volume, Genesis Therapeutics Inc is #26,547 of 119,880 employers nationally and #4,468 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.